Jianming Wang

1.5k citations
46 papers · 869 indexed · h-index 17
Topics
Cholangiocarcinoma and Gallbladder Cancer Studies (12 papers)Ferroptosis and cancer prognosis (6 papers)Cancer-related molecular mechanisms research (6 papers)

In The Last Decade

Jianming Wang

43 papers receiving 853 citations

Peers

Jianming Wang
Comparison fields: 5 of 87
  • Molecular Biology 391
  • Pulmonary and Respiratory Medicine 256
  • Cancer Research 244
  • Oncology 203
  • Surgery 180
Replace Maya Srikanth with:
Maya Srikanth United States
Thomas Schwarzmayr Germany
N. Skuli United States
Jin Fan China
Vishnu Chintalgattu United States
Eri Sasabe Japan
Huanhuan Joyce Chen United States
Soniya Savant Germany
Ye Wu China
Jianming Wang relative to Maya Srikanth United States Maya Srikanth's profile →
Citations per field
00.5×7.0×
Maya Srikanth · 1×
Citations per year

Countries citing papers authored by Jianming Wang

Since Specialization
Citations

This map shows the geographic impact of Jianming Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianming Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianming Wang more than expected).

Fields of papers citing papers by Jianming Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianming Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianming Wang. The network helps show where Jianming Wang may publish in the future.

Co-authorship network of co-authors of Jianming Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Jianming Wang. A scholar is included among the top collaborators of Jianming Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianming Wang. Jianming Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 5
4 6
5 1
6 16
7 10
8 18
9 10
10 42
11 22
12 31
13 7
14 27
15 0
16 108
17 7
18 67
19 11
20 1

About Jianming Wang

Jianming Wang is a scholar working on Cancer Research, Business and International Management and Oncology, having authored 46 papers that have together received 869 indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (12 papers), Ferroptosis and cancer prognosis (6 papers) and Cancer-related molecular mechanisms research (6 papers). The work is most often cited by research in Cancer Research (244 citations), Pulmonary and Respiratory Medicine (256 citations) and Oncology (203 citations). Jianming Wang has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Juan Liu, Zhaohui Feng, Cen Zhang, Wenwei Hu, Wei Yao, Xiangyü Li, Yun Lü, Stephanie J. Murphy, Abby L. Dotson and Julie A. Saugstad. Their work appears in journals such as Journal of Clinical Oncology, Scientific Reports and International Journal of Molecular Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026